Razavi Shearer, D., Gamkrelidze, I., Nguyen, M. H., Chen, D. S., Van Damme, P., Abbas, Z. ... Razavi, H. (2018). Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. The Lancet Gastroenterology & Hepatology, 3. (6), 383-403. doi: 10.1016/S2468-1253(18)30056-6
Razavi Shearer, Devin, et al. "Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study." The Lancet Gastroenterology & Hepatology, vol. 3, no. 6, 2018, pp. 383-403. https://doi.org/10.1016/S2468-1253(18)30056-6
Razavi Shearer, Devin, Ivane Gamkrelidze, Mindie H Nguyen, Ding Shinn Chen, Pierre Van Damme, Zaigham Abbas, Maheeba Abdulla, et al. "Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study." The Lancet Gastroenterology & Hepatology 3, no. 6 (2018): 383-403. https://doi.org/10.1016/S2468-1253(18)30056-6
Razavi Shearer, D., et al. (2018) 'Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study', The Lancet Gastroenterology & Hepatology, 3(6), pp. 383-403. doi: 10.1016/S2468-1253(18)30056-6
Razavi Shearer D, Gamkrelidze I, Nguyen MH, Chen DS, Van Damme P, Abbas Z, and sur.. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. The Lancet Gastroenterology & Hepatology [Internet]. 2018 June [cited 2024 August 19];3(6):383-403. doi: 10.1016/S2468-1253(18)30056-6
D. Razavi Shearer, et al., "Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study", The Lancet Gastroenterology & Hepatology, vol. 3, no. 6, pp. 383-403, June 2018. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:441403. [Accessed: 19 August 2024]